Trapped in a vicious loop: Toll-like receptors sustain the spontaneous cytokine production by rheumatoid synovium

Arthritis Research and Therapy

Volumn 13, Issue 2, 2011, Pages

  Abdollahi Roodsaz, Shahla ^a   van de Loo, Fons A J ^a   van den Berg, Wim B ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; IMIQUIMOD; MIANSERIN; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 7;

CYTOKINE PRODUCTION; EDITORIAL; EXPLANT; HUMAN; NONHUMAN; PATHOGENESIS; REGULATORY T LYMPHOCYTE; RHEUMATOID ARTHRITIS; SYNOVIUM; TISSUE CULTURE; DRUG ANTAGONISM; FEMALE; IMMUNOLOGY; MALE; NOTE;

ARTHRITIS, RHEUMATOID; FEMALE; HUMANS; MALE; SYNOVIAL MEMBRANE; TOLL-LIKE RECEPTOR 2;

EID: 79955589106     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar3287     Document Type: Editorial

References (15)

1. Nic An Ultaigh S, Saber TP, McCormick J, Connolly M, Dellacasagrande J, Keogh B, McCormack W, Reilly M, O'Neill LA, McGuirk P, Fearon U, Veale DJ. Blockade of Toll-like receptor 2 prevents spontaneous cytokine release from rheumatoid arthritis ex vivo synovial explant cultures. Arthritis Res Ther 2011, 13:R33. 10.1186/ar3261, 21345222.
2. Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol 2010, 11:373-384. 10.1038/ni.1863, 20404851.
3. Brennan FM, McInnes IB. Evidence that cytokines play a role in rheumatoid arthritis. J Clin Invest 2008, 118:3537-3545. 10.1172/JCI36389, 2575731, 18982160.
4. Brentano F, Kyburz D, Gay S. Toll-like receptors and rheumatoid arthritis. Methods Mol Biol 2009, 517:329-343.
5. Shiozawa K, Hino K, Shiozawa S. Alternatively spliced EDA-containing fibronectin in synovial fluid as a predictor of rheumatoid joint destruction. Rheumatology (Oxford) 2001, 40:739-742. 10.1093/rheumatology/40.7.739, 11477277.
6. Abdollahi-Roodsaz S, Joosten LA, Koenders MI, van den Brand BT, van de Loo FA, van den Berg WB. Local interleukin-1-driven joint pathology is dependent on toll-like receptor 4 activation. Am J Pathol 2009, 175:2004-2013. 10.2353/ajpath.2009.090262, 2774064, 19834062.
7. van den Berg WB, van Lent PL, Joosten LA, Abdollahi-Roodsaz S, Koenders MI. Amplifying elements of arthritis and joint destruction. Ann Rheum Dis 2007, 66(Suppl 3):iii45-iii48. 10.1136/ard.2007.079830, 2095284, 17934095.
8. Abdollahi-Roodsaz S, Joosten LA, Koenders MI, Devesa I, Roelofs MF, Radstake TR, Heuvelmans-Jacobs M, Akira S, Nicklin MJ, Ribeiro-Dias F, van den Berg WB. Stimulation of TLR2 and TLR4 differentially skews the balance of T cells in a mouse model of arthritis. J Clin Invest 2008, 118:205-216. 10.1172/JCI32639, 2104479, 18060042.
9. Abdollahi-Roodsaz S, Joosten LA, Roelofs MF, Radstake TR, Matera G, Popa C, van der Meer JW, Netea MG, van den Berg WB. Inhibition of Toll-like receptor 4 breaks the inflammatory loop in autoimmune destructive arthritis. Arthritis Rheum 2007, 56:2957-2967. 10.1002/art.22848, 17763416.
10. Sacre SM, Andreakos E, Kiriakidis S, Amjadi P, Lundberg A, Giddins G, Feldmann M, Brennan F, Foxwell BM. The Toll-like receptor adaptor proteins MyD88 and Mal/TIRAP contribute to the inflammatory and destructive processes in a human model of rheumatoid arthritis. Am J Pathol 2007, 170:518-525. 10.2353/ajpath.2007.060657, 1851858, 17255320.
11. Kenny EF, Talbot S, Gong M, Golenbock DT, Bryant CE, O'Neill LA. MyD88 adaptor-like is not essential for TLR2 signaling and inhibits signaling by TLR3. J Immunol 2009, 183:3642-3651. 10.4049/jimmunol.0901140, 19717524.
12. Sacre SM, Lo A, Gregory B, Simmonds RE, Williams L, Feldmann M, Brennan FM, Foxwell BM. Inhibitors of TLR8 reduce TNF production from human rheumatoid synovial membrane cultures. J Immunol 2008, 181:8002-8009.
13. Abdollahi-Roodsaz S, Koenders MI, Joosten LA, van de Loo FA, van den Berg WB. Toll-like receptor 4 blockade ameliorates murine and humanized models of rheumatoid arthritis: a comparison with IL-1 and TNF blockade. Paper presented at: 73rd Annual Scientific Meeting of the American College of Rheumatology/Association of Rheumatology Health Professionals; 20 October 2009; Philadelphia, PA. Presentation 1897,
14. van der Pouw Kraan TC, van Gaalen FA, Kasperkovitz PV, Verbeet NL, Smeets TJ, Kraan MC, Fero M, Tak PP, Huizinga TW, Pieterman E, Breedveld FC, Alizadeh AA, Verweij CL. Rheumatoid arthritis is a heterogeneous disease: evidence for differences in the activation of the STAT-1 pathway between rheumatoid tissues. Arthritis Rheum 2003, 48:2132-2145. 10.1002/art.11096, 12905466.
15. Sutmuller RP, den Brok MH, Kramer M, Bennink EJ, Toonen LW, Kullberg BJ, Joosten LA, Akira S, Netea MG, Adema GJ. Toll-like receptor 2 controls expansion and function of regulatory T cells. J Clin Invest 2006, 116:485-494. 10.1172/JCI25439, 1332026, 16424940.